Although GSK-3β has been reported to have a major role in glomeruli podocyte injury [18–20, 62], our study is the first report demonstrating the involvement of the lncRNA DLX6-AS1-miR-346-GSK-3β pathway in the pathogenesis of DN. This evidence concerns the gene DLX6 and liver dysplastic nodule.